Skip to search formSkip to main contentSkip to account menu

ITF-1697

Known as: ITF1697 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
ITF1697, a Stable Lys-Pro-Containing Peptide, Inhibits Weibel-Palade Body Exocytosis Induced by Ischemia/Reperfusion and Pressure Elevation
A number of Lys-Pro-containing short peptides have been described as possessing a variety of biological activities in vitro… 
2004
2004
The effect of ITF-1697 on reperfusion in patients undergoing primary angioplasty. Safety and efficacy of a novel tetrapeptide, ITF-1697.
2004
2004
Assessment of the Safety and Efficacy of the Novel Tetrapeptide ITF-1697 on Infarct Size after Primary PTCA in Acute Myocardial Infarction
AbstractObjective and design:ITF-1697 is a chemically modified LYS-Pro tetrapeptide that corresponds to sequence 113–116 of C… 
2003
2003
Protection against reperfusion injury with ITF-1697 in acute myocardial infarction: The PARI-MI trial
2003
2003
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)